Familial Hypercholesterolaemia (adult)
The UK NSC policy on Familial Hypercholesterolaemia screening in adults
|Last review completed
|Next review due in
|| Systematic population screening programme not recommended
A national screening programme for FH is not recommended.
|| Last external review
What is screening?
Screening is a process of identifying apparently healthy people who may be at increased risk of a disease or condition. They can then be offered information, further tests and appropriate treatment to reduce their risk and/or any complications arising from the disease or condition.
It is important to ensure that the benefits and downsides of screening have been properly thought through. The UK National Screening Committee (UK NSC) is responsible for reviewing screening policies every 3 years and making recommendations to ministers in the 4 UK countries about whether to not a screening programme for a certain condition should be set up.
» Find out more about screening, the role of the UK NSC or the policy review process
More about Familial Hypercholesterolaemia (adult)
Familial hypercholesterolaemia (or hyperlipidaemias) are inherited metabolic disorders which include harmful disorders resulting in an excess of cholesterol and/or triglyceride in the blood. Cholesterol is transported round the body in combination with proteins, known as lipoproteins, low density lipoproteins (LDL) and beneficial high density lipoproteins (HDL). Triglyceride travels within very low density lipoproteins (VLDL) and chylomicrons.
» Read more about familial hypercholesterolaemia on NHS Choices
• British Heart Foundation
• British Inherited Metabolic Disease Group
• Genetic Alliance UK
• HEART UK
• Royal College of Pathologists
• Royal College of Physicians
• Royal College of Physicians and Surgeons of Glasgow
• Royal College of Physicians of Edinburgh
• Scottish Lipid Forum
The stakeholder groups will be involved when the policy is next reviewed.
If you think your organisation should be added, please
More about the policy review process, including the role of stakeholders,
can be found in the guide to Engaging with the UK NSC's policy review process.
Summary of Policy and Consultation Responses for Familial Hypercholesterolaemia (PDF document, 598KB, 15/12/11)
More optionsGo to top